Koyfin Home > Directory > Health Care > Acceleron Pharma > EV / EBITDA (ltm)

Acceleron Pharma EV / EBITDA (ltm) Chart (XLRN)

Acceleron Pharma annual/quarterly EV / EBITDA (ltm) from 2013 to 2014. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Acceleron Pharma EV / EBITDA (ltm) for the quarter ending May 05, 2014 was 114.69 a -0.42% decrease of -0.48 year over year
  • Acceleron Pharma EV / EBITDA (ltm) for the last 12 months ending May 05, 2014 was 114.69 a -0.42% decrease of -0.48 year over year
  • Acceleron Pharma Annual EV / EBITDA (ltm) for 2014 was 114.69 a -3.45% decrease of -3.96 from 2013
  • Acceleron Pharma Annual EV / EBITDA (ltm) for 2014 was 118.65 a 0.30% increase of 0.36 from 2013
  • Acceleron Pharma Annual EV / EBITDA (ltm) for 2014 was 118.29 a 2.64% increase of 3.12 from 2013
Other Valuation Metrics:
  • Acceleron Pharma Market Cap for the quarter ending March 03, 2018 was $1,776m a 33.91% increase of 602m year over year
  • Acceleron Pharma Price / Book for the quarter ending March 03, 2018 was 4.85 a -16.20% decrease of -0.78 year over year
  • Acceleron Pharma Enterprise Value for the quarter ending March 03, 2018 was $1,499m a 31.12% increase of 466m year over year
View Chart On Koyfin

Quarterly XLRN EV / EBITDA (ltm) Data

05/2014114.69
05/2014118.65
05/2014118.29
05/2014115.17
05/2014116.09
05/2014118.45
05/2014112.37
05/2014121.17
05/2014122.48
05/2014124.32

Annual XLRN EV / EBITDA (ltm) Data

2014114.69
2014118.65
2014118.29
2014115.17
2014116.09
2014118.45
2014112.37
2014121.17
2014122.48
2014124.32